A Critique of Phenobarbital Tapers With Buprenorphine or Methadone Initiations
Author:
- 17 April 2025
- journal article
- letter
- Published by Wolters Kluwer Health in Journal of Addiction Medicine
- Vol. 20 (1) , 138
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Evaluation of Clinical Outcomes Associated With Phenobarbital With Taper Compared to No Taper for the Management of Alcohol Withdrawal SyndromeAnnals of Pharmacotherapy, 2024
- Phenobarbital for alcohol withdrawal in the context of the opioid epidemic: a neglected caveatAddiction, 2023
- Phenobarbital use in benzodiazepine and z-drug detoxification: a single-centre 15-year observational retrospective study in clinical practiceInternal and Emergency Medicine, 2022
- Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trialThe Lancet, 2018
- Safety and effectiveness of a fixed-dose phenobarbital protocol for inpatient benzodiazepine detoxificationJournal of Substance Abuse Treatment, 2012